by Emmitt Barry, Worthy News Correspondent
(Worthy News) – The World Health Organization (WHO) announced on Monday an initiative to accelerate the development and accessibility of bird flu vaccines using advanced messenger RNA technology to better prepare for the next pandemic.
In a press release, the WHO announced that Argentinian manufacturer Sinergium Biotech will lead this effort, utilizing the mRNA Technology Transfer Programme from the World Health Organization (WHO) and the Medicines Patent Pool (MPP).
“This initiative exemplifies why WHO established the mRNA Technology Transfer Programme – to foster greater research, development and production in low- and middle-income countries, so that when the next pandemic arrives, the world will be better prepared to mount a more effective and more equitable response,” said Dr. Tedros Adhanom Ghebreyesus, WHO Director-General.
The WHO claims that avian influenza viruses pose a significant public health risk due to their widespread circulation in animals and potential to cause a future pandemic.
The H5N1 bird flu first emerged in 1996, but since 2020, the WHO claims there has been an exponential increase in outbreaks among birds. This surge has been accompanied by the virus increasingly jumping to mammals, including cattle on US farms, and a few human cases.
Martin Friede, head of the WHO’s vaccine research unit, highlighted the advantages of developing mRNA-based vaccines for establishing sustainable production capacity. Previous efforts to boost influenza vaccine production in developing countries often faltered, with facilities focused on egg-based pandemic influenza jabs closing once the threat dissipated and governments stopped procuring doses.
“The advantage of mRNA is that, in theory, we can make a COVID vaccine, we can make H5N1 vaccines, but also many other vaccines and importantly also therapeutics,” Friede told reporters.
Friede stated that half of the manufacturers in the program have already started installing the necessary equipment to develop and produce mRNA-based vaccines, enabling them to respond much more swiftly if a disaster strikes again.
Copyright 1999-2026 Worthy News. This article was originally published on Worthy News and was reproduced with permission.
Latest News from Worthy News
The Trump administration has finalized a sweeping reciprocal trade agreement with Taiwan, confirming a 15 percent U.S. tariff rate on Taiwanese imports while securing broad new market access and purchase commitments for American goods.
Democrats are applauding White House border czar Tom Homan’s Thursday announcement that immigration enforcement operation in Minnesota will end next week.
Democrats in the U.S. Senate tanked the Homeland Security full-year funding bill in a last-ditch vote Thursday, all but guaranteeing a partial government shutdown starting Saturday.
Mourners in a remote Canadian town grappled Thursday with the aftermath of one of the country’s deadliest school shootings in decades, as families, survivors and leaders reacted to the tragedy that left eight victims — most of them children — dead, along with the 18-year-old suspect.
A gunman who opened fire at a school in southern Thailand’s Hat Yai city on Wednesday wounded a teacher and a student before being detained, authorities said, in a rare attack that sent students and staff into panic.
The Republican-led House of Representatives has passed the Safeguard American Voter Eligibility (SAVE) America Act, advancing legislation that would require proof of citizenship to register to vote and photo identification at the polls. The bill now heads to the Senate, where its future remains uncertain amid strong Democratic opposition.
Israel’s Ministry of Defense announced on Wednesday that its advanced David’s Sling air and missile defense system has completed a series of complex modernized tests, a development officials say bolsters the country’s defensive posture as tensions with Iran escalate and the United States prepares military options that could include direct strikes.